Safe and pragmatic use of sodium–glucose co-transporter 2 inhibitors in type 2 diabetes mellitus: South Asian Federation of Endocrine Societies consensus statement

Diabetes prevalence shows a continuous increasing trend in South Asia. Although well-established treatment modalities exist for type 2 diabetes mellitus (T2DM) management, they are limited by their side effect profile. Sodium–glucose co-transporter 2 inhibitors (SGLT2i) with their novel insulin-inde...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Ghosh, Sujoy, Aamir, A. H., Ahmed, Md. Tofail, Amin, Mohammod Feroz, Bajaj, Sarita, Baruah, Manash P., Bulugahapitiya, Uditha, Das, A. K., Giri, Mimi, Gunatilake, Sonali, Mahar, Saeed A., Pathan, Md. Faruque, Qureshi, Nazmul Kabir, Raza, S. Abbas, Sahay, Rakesh, Shakya, Santosh, Shreshta, Dina, Somasundaram, Noel, Sumanatilleke, Manilka, Unnikrishnan, A. G., Wijesinghe, Achini Madushani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240067/
https://www.ncbi.nlm.nih.gov/pubmed/28217523
http://dx.doi.org/10.4103/2230-8210.196029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240067/
https://www.ncbi.nlm.nih.gov/pubmed/28217523
http://dx.doi.org/10.4103/2230-8210.196029

Ejemplares similares